Primaquine: Difference between revisions
From IDWiki
(Created page with "== Background == * Antimalarial medication * Indications include malaria and Pneumocystis == Dosing == * Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial * Pneumocystis jirovecii: 30 mg p.o. once daily in combination with clindamycin for 21 days === Renal Dosing === * No dose adjustments. == Safety == * For G6PD deficiency, should be avoided or dose-reduced Category:Antimicrobials Category:Antimal...") |
No edit summary |
||
| Line 6: | Line 6: | ||
== Dosing == |
== Dosing == |
||
* '''Note:''' in Canada, the form is as a phosphate oral tablet, where 26.3 mg is equivalent to 15 mg primaquine base |
|||
* Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial |
* Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial |
||
* [[Pneumocystis jirovecii]]: 30 mg p.o. once daily in combination with [[clindamycin]] for 21 days |
* [[Pneumocystis jirovecii]]: 30 mg p.o. once daily in combination with [[clindamycin]] for 21 days |
||
Latest revision as of 15:54, 15 October 2024
Background
- Antimalarial medication
- Indications include malaria and Pneumocystis
Dosing
- Note: in Canada, the form is as a phosphate oral tablet, where 26.3 mg is equivalent to 15 mg primaquine base
- Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial
- Pneumocystis jirovecii: 30 mg p.o. once daily in combination with clindamycin for 21 days
Renal Dosing
- No dose adjustments.
Safety
- For G6PD deficiency, should be avoided or dose-reduced
